Clinical Presentation Of Type 1 Glycogen Storage Disease

Hyperlipidemia

Hyperlipidemia is a major symptom of type 1 glycogen storage disease, and it typically begins in infancy. Affected patients often display both elevated total cholesterol and elevated triglycerides. Simple blood tests are needed to evaluate cholesterol levels, and these can be performed at the doctor's office. Generally, patients will have to be placed on medication to lower cholesterol levels, and frequent blood tests might be necessary to plan the most effective cholesterol-lowering treatment.

For children, a normal total cholesterol reading is 170mg/dL or below; readings of between 170mg/dL and 199mg/dL are considered borderline, and anything above is classified as elevated. In adults, total cholesterol readings of less than 200mg/dL are categorized as optimal, and readings between 200mg/dL and 239mg/dL are borderline. Anything at or above 240mg/dL is categorized as high.

To reduce cholesterol levels, most patients with type 1 glycogen storage disease are started on prescription medications known as statins. These drugs work by suppressing the function of a liver enzyme that produces cholesterol. While taking statins and other cholesterol-lowering medications, patients should be aware of the potential side effects. In particular, statins may cause headaches, sleeping problems, abdominal pain, diarrhea, and muscle pain or weakness. Patients who experience any muscle pain should inform their physician immediately as this could sometimes be a sign of serious complications.

Discover more symptoms of type 1 glycogen storage disease now.